Acerca de

COVID-19 vaccination in Haiti

Funding

Status, as of 14 November 2022

Contributions

Our funding gap

US$ 329 mn

CT Nov 2022.png

Support the ACT-Accelerator transition from emergency mode to sustainable disease control

 

The Transition Plan funding gap of US$ 386m  (October 2022 to March  2023) is based on actual demand for COVID-19 tools rather than the funding needed to reach global targets.  It is a minimum, with funding urgently required for the highest priority needs. 

 

Funding will be needed beyond the transition period into the medium and longer term to support the integration of COVID-19 work into core/routine health programmes. This will need to be complimented by additional funding to support the recovery from COVID-19 related setbacks to other critical health services.

 

Everyone has a role to play.

For more detailed information:

act-accelerator-strategic-plan cover.png

ACT-Accelerator Transition Plan (1 Oct 2022 to 31 Mar 2023)

Plan of how ACT-A will support countries as the world transitions to long-term COVID-19 control.  

act-accelerator-strategic-plan cover.png

Consolidated Financing Framework for ACT-A Agency & In-Country Needs

Financial needs broken down by agency, together with fair share contributions requested from higher income countries.

How to contribute  

Grant funding is needed by ACT-Accelerator agencies, which are responsible for implementation and reporting on the use of funds. 

Institutional donors should contact agencies directly (click to generate email to relevant contact): CEPI, FIND, Gavi, Global Fund, GFF, UNICEF, UnitaidWellcome, WHO.  

Individuals can support the ACT-Accelerator by contributing to one of its constituent agencies:

 

  • WHO Foundation’s Go Give One campaign for Vaccines for everyone, everywhere

  • UNICEF’s campaign for the ACT-Accelerator

  • Global Fund, which drives work on diagnostics and the Health Systems & Response Connector

  • Gavi to support COVID-19 vaccination